Skip to content

Diabetes and Ayurved

A COMPARATIVE CLINICAL STUDY OF VAMANA KARMA AND CHITRAKADIKWATH IN THE MANAGEMENT OF STHOOL PRAMEHI W.S.R. TO TYPE 2 DIABETES MELLITUS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013525
Enrollment
30
Registered
2018-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PRAMEHI

Interventions

Intervention1: Group A vaman karma with chitrakadi kwath: nil Control Intervention1: Group B CHITRAKADI KWATH: NIL

Sponsors

GOVERMENT AKANDANAND AYURVED COLLEGE AHMEDABAD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical signs and symptoms of the disease according to Ayurveda well as Modern science. 1 Patients of Prameha having BMI 25 to 35 2 Patient of NIDDM with blood sugar level more then - F.B.S.- 126 mg/dl or P.P.B.S.-180 mg/dl. 3 Age group of 16-60 years. 4 Disease chronicity 10 year. 5 Patient otherwise healthy and fit for Shodhana(Vamana) and Chirakadikwath as per the Ayurvedic text

Exclusion criteria

Exclusion criteria: Patients of Prameha having BMI 35 1 Patients of Type-1 Diabetes or the patients of Type-2 Diabetes taking Insulin. 2 Patients having complications of Diabetes like Nephropathy, Retinopathy, Diabetic Foot,Carbuncles etc. 3 Age 60 years. 4 Patients having Diabetes in association with other endocrinopathies like Pheochromocytoma, Acromegaly, Cushingâ??s syndrome, Hyperthyroidism etc. 5 Patients having drug or chemical induced Type-II Diabetes, like glucocorticoids induced or thyroid hormone induced etc. 6 Patients with genetic syndromes associated with Type-II Diabetes like Downâ??s syndrome, Klinefelterâ??s Syndrome, and Turnerâ??s syndrome etc. 7 Patients complicated with any cardiovascular diseases, renal diseases, Carcinoma or any other disease effecting multiple body systems and pregnant women etc.

Design outcomes

Primary

MeasureTime frame
All the signs and symptoms of Pramehi will be assigned score depending upone their severity to assess the effect of the drugsat the time of before treatment and after treatment.Timepoint: After 3 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactNiharika Jitendrakumar Prajapati

GOVT. AKHANDANAND AYURVED COLLEGE,AHMEDABAD

ramayu@gmail.com9426289960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026